UNSPSC 51434904: Aliskiren/valsartan

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434904 Aliskiren/valsartan is a Commodity code representing individual pharmaceutical products, though the recent state and local procurement activity under this code does not align with the code's nominal scope. The City of Tampa's Fire Rescue Department issued an IFB in April 2026 for Advanced Life Support Medications—specifically Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—none of which are aliskiren/valsartan combinations. This mismatch suggests either miscoding in the procurement system or that the UNSPSC category is being applied to emergency medical supply bundles rather than to the specific pharmaceutical compound the code nominally describes. The scope of work involves supplying pre-measured vials and injections with strict expiration-date and delivery requirements (nine-month minimum shelf life, ten-day delivery windows) and comprehensive regulatory documentation including Safety Data Sheets and WCAG 2.2 accessibility conformance reports.

The geographic activity centers on Florida, with the Tampa Fire Rescue procurement representing the only recent documented opportunity under this code. The City of Tampa's Purchasing Department estimated the contract value at $40,000 for a one-year initial term with two optional one-year renewals and up to three additional 30-day extensions at the City's discretion. The solicitation carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount (not to exceed $10,000) for SLBE participation. No additional state or local jurisdictions appear in recent activity for this code, indicating minimal current procurement volume or consistent miscoding across jurisdictions. Bidders should verify the actual pharmaceutical requirements in any opportunity tagged to this code before pursuing, as the Tampa example demonstrates substantial divergence between the code's nominal scope and the medications actually being solicited.